News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
584,454 Results
Type
Article (18865)
Company Profile (164)
Press Release (565348)
Multimedia
Podcasts (21)
Webinars (10)
Section
Business (194097)
Career Advice (897)
Deals (31000)
Drug Delivery (50)
Drug Development (68882)
Employer Resources (49)
FDA (12318)
Job Trends (10938)
News (285029)
Policy (23083)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1321)
Accelerated approval (49)
ADA (26)
Adcomms (12)
Allergies (145)
Alliances (39549)
ALS (163)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (420)
Approvals (12916)
Artificial intelligence (486)
ASCO (258)
Autoimmune disease (293)
Automation (49)
Bankruptcy (302)
Best Places to Work (8801)
BIO (49)
Biologics (2)
BIOSECURE Act (13)
Biosimilars (139)
BioSpace Insights (38)
Biotechnology (113)
Bladder cancer (196)
Brain cancer (61)
Breast cancer (693)
Cancer (5379)
Cardiovascular disease (349)
Career advice (768)
Career pathing (16)
CAR-T (283)
CDC (10)
Celiac Disease (2)
Cell therapy (749)
Cervical cancer (47)
Clinical research (62273)
Collaboration (1645)
Commercialization (6)
Company closure (2)
Compensation (1492)
Complete response letters (115)
COVID-19 (1465)
CRISPR (110)
C-suite (1000)
Cystic fibrosis (115)
Data (7629)
Denatured (7)
Depression (141)
Dermatology (89)
Diabetes (471)
Diagnostics (5489)
Digital health (44)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (237)
Drug pricing (28)
Drug shortages (9)
Duchenne muscular dystrophy (217)
Earnings (82725)
Editorial (19)
Employer branding (6)
Employer resources (48)
Events (98710)
Executive appointments (872)
FDA (15836)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (29)
Funding (1343)
Gene editing (214)
Generative AI (25)
Gene therapy (535)
GLP-1 (558)
Government (1967)
Grass and pollen (5)
Guidances (367)
Healthcare (12810)
Hematology (147)
HIV (70)
Huntington's disease (42)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (93)
Immunology and inflammation (194)
Immuno-oncology (86)
Indications (200)
Infectious disease (1713)
Inflammatory bowel disease (165)
Inflation Reduction Act (4)
Influenza (96)
Intellectual property (290)
Interviews (158)
IPO (14646)
IRA (10)
Job creations (2523)
Job search strategy (655)
JPM (19)
Kidney cancer (24)
Labor market (18)
Layoffs (269)
Leadership (13)
Legal (5681)
Licensing (13)
Liver cancer (82)
Longevity (23)
Lung cancer (729)
Lymphoma (442)
Machine learning (41)
Management (17)
Manufacturing (807)
Marketing (10)
MASH (163)
Medical device (10743)
Medtech (10924)
Mergers & acquisitions (17663)
Metabolic disorders (1050)
mRNA (124)
Multiple sclerosis (154)
NASH (11)
Neurodegenerative disease (332)
Neuropsychiatric disorders (72)
Neuroscience (2638)
NextGen: Class of 2026 (4251)
Non-profit (1690)
Now hiring (7)
Obesity (390)
Opinion (109)
Ovarian cancer (203)
Pain (219)
Pancreatic cancer (311)
Parkinson's disease (303)
Partnered (21)
Patents (563)
Patient recruitment (706)
Peanut (50)
People (47786)
Pharmaceutical (35)
Pharmacy benefit managers (11)
Phase 1 (19692)
Phase 2 (27745)
Phase 3 (19872)
Pipeline (9599)
Policy (94)
Postmarket research (1957)
Preclinical (7868)
Press Release (52)
Prostate cancer (264)
Psychedelics (45)
Radiopharmaceuticals (265)
Rare diseases (910)
Real estate (4207)
Recruiting (20)
Regulatory (20029)
Reports (24)
Research institute (1393)
Resumes & cover letters (142)
Rett syndrome (45)
RNA editing (13)
RSV (60)
Schizophrenia (151)
Series A (229)
Series B (179)
Service/supplier (5)
Sickle cell disease (99)
Special edition (8)
Spinal muscular atrophy (111)
Sponsored (25)
Startups (2707)
Stomach cancer (7)
Supply chain (72)
Tariffs (14)
The Weekly (14)
Vaccines (574)
Venture capital (47)
Weight loss (184)
Women's health (95)
Worklife (4)
Date
Today (78)
Last 7 days (316)
Last 30 days (2068)
Last 365 days (24346)
2026 (16085)
2025 (24256)
2024 (28499)
2023 (32707)
2022 (41691)
2021 (45024)
2020 (41430)
2019 (31182)
2018 (23651)
2017 (24475)
2016 (23173)
2015 (29441)
2014 (25165)
2013 (21163)
2012 (23124)
2011 (23513)
2010 (22911)
Location
Africa (419)
Alabama (86)
Alaska (5)
Arizona (335)
Arkansas (12)
Asia (28757)
Australia (4290)
California (13369)
Canada (3627)
China (1131)
Colorado (543)
Connecticut (533)
Delaware (302)
Europe (51668)
Florida (1998)
Georgia (422)
Hawaii (4)
Idaho (53)
Illinois (889)
India (81)
Indiana (523)
Iowa (24)
Japan (492)
Kansas (126)
Kentucky (39)
Louisiana (34)
Maine (59)
Maryland (1453)
Massachusetts (9211)
Michigan (337)
Minnesota (650)
Mississippi (4)
Missouri (115)
Montana (28)
Nebraska (20)
Nevada (148)
New Hampshire (67)
New Jersey (3283)
New Mexico (24)
New York (3360)
North Carolina (1565)
North Dakota (10)
Northern California (6719)
Ohio (351)
Oklahoma (15)
Oregon (26)
Pennsylvania (2553)
Puerto Rico (23)
Rhode Island (39)
South America (627)
South Carolina (81)
South Dakota (1)
Southern California (5475)
Tennessee (151)
Texas (2180)
United States (45328)
Utah (401)
Vermont (1)
Virginia (268)
Washington D.C. (44)
Washington State (1047)
West Virginia (1)
Wisconsin (105)
Wyoming (2)
584,454 Results for "complete genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Complete Genomics Appoints Lauren Selig to Board of Directors
August 19, 2026
·
3 min read
Press Releases
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Clinical Study on Track to Meet Primary Endpoints with Interim Data Demonstrating Blood-Based Assay Capable of Predicting Relapse Risk Through Analysis of Genomic Instability and Telomere Architecture
July 16, 2026
·
8 min read
Press Releases
Moss Genomics Inc. Provides Default Status Disclosure and Update on Continuous Disclosure Review
August 25, 2026
·
4 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
Press Releases
Biogen Completes Acquisition of RayThera Inc.
August 7, 2026
·
7 min read
Press Releases
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
·
3 min read
Press Releases
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
August 18, 2026
·
2 min read
Press Releases
Telo Genomics Grants Stock Options
August 4, 2026
·
1 min read
Press Releases
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
June 9, 2026
·
6 min read
Press Releases
Ecotone AI Breaks the Genomics Cost Barrier, Cutting Genome Processing from $100 to Under $1
New GPU-powered system reduces whole-genome processing time from hours to minutes, unlocking population-scale genetic discovery and accelerating rare disease drug development
February 25, 2026
·
1 min read
1 of 58,446
Next
